Roger J. Watson

2.4k total citations
32 papers, 2.1k citations indexed

About

Roger J. Watson is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Roger J. Watson has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Roger J. Watson's work include Cancer-related Molecular Pathways (12 papers), Herpesvirus Infections and Treatments (10 papers) and Virus-based gene therapy research (5 papers). Roger J. Watson is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Herpesvirus Infections and Treatments (10 papers) and Virus-based gene therapy research (5 papers). Roger J. Watson collaborates with scholars based in United Kingdom, United States and Malaysia. Roger J. Watson's co-authors include J. Barklie Clements, Lynn W. Enquist, Neil Wilkie, John H. Weis, John S. Salstrom, Mark K. Saville, Eric W.‐F. Lam, Steven Catchpole, Brian David Dynlacht and Hein te Riele and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Roger J. Watson

32 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger J. Watson United Kingdom 20 1.1k 1.1k 545 516 410 32 2.1k
R J Watson United Kingdom 22 694 0.6× 1.2k 1.1× 321 0.6× 645 1.3× 345 0.8× 25 2.0k
Hans-Gerhard Burgert Germany 30 830 0.8× 1.0k 1.0× 1.3k 2.4× 542 1.1× 1.2k 3.0× 49 2.7k
M A Baluda United States 34 640 0.6× 1.7k 1.6× 1.0k 1.9× 472 0.9× 577 1.4× 96 3.1k
Laura Menotti Italy 27 1.7k 1.6× 589 0.6× 906 1.7× 530 1.0× 570 1.4× 43 2.4k
M P Calos United States 18 374 0.3× 1.7k 1.6× 777 1.4× 366 0.7× 210 0.5× 24 2.4k
Philippe Mangeot France 20 579 0.5× 1.3k 1.3× 501 0.9× 171 0.3× 415 1.0× 52 2.1k
Rebecca I. Montgomery United States 13 2.0k 1.8× 572 0.5× 825 1.5× 291 0.6× 1.3k 3.1× 19 3.2k
Jaquelin P. Dudley United States 28 383 0.4× 1.1k 1.1× 777 1.4× 448 0.9× 1.1k 2.8× 77 2.5k
F Puvion-Dutilleul France 29 472 0.4× 2.6k 2.5× 863 1.6× 282 0.5× 380 0.9× 94 3.4k
S D Showalter United States 21 655 0.6× 789 0.7× 323 0.6× 249 0.5× 610 1.5× 45 1.9k

Countries citing papers authored by Roger J. Watson

Since Specialization
Citations

This map shows the geographic impact of Roger J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger J. Watson more than expected).

Fields of papers citing papers by Roger J. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger J. Watson. The network helps show where Roger J. Watson may publish in the future.

Co-authorship network of co-authors of Roger J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Roger J. Watson. A scholar is included among the top collaborators of Roger J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger J. Watson. Roger J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashid, Nurshamimi Nor, et al.. (2016). HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block. Virology Journal. 13(1). 2–2. 8 indexed citations
2.
Watson, Roger J., et al.. (2016). A Remotely-Operated Facility for Evaluation of Post-Combustion CO2 Capture Technologies on Industrial Sites. International Journal of Online and Biomedical Engineering (iJOE). 12(6). 43–50. 1 indexed citations
3.
Rashid, Nurshamimi Nor, Rohana Yusof, & Roger J. Watson. (2014). A B-myb--DREAM complex is not critical to regulate the G2/M genes in HPV-transformed cell lines.. PubMed. 34(11). 6557–63. 2 indexed citations
4.
Millour, Julie, et al.. (2012). Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(8). 855–862. 72 indexed citations
5.
Soeiro, Inês, Azim Mohamedali, Hanna Romańska, et al.. (2006). p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo. Molecular and Cellular Biology. 26(16). 6170–6184. 13 indexed citations
6.
Joaquin, Manel & Roger J. Watson. (2003). The Cell Cycle-regulated B-Myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57 by Interacting with Its Cyclin-binding Domain. Journal of Biological Chemistry. 278(45). 44255–44264. 24 indexed citations
7.
Joaquin, Manel, Maria João Bessa, Mark K. Saville, & Roger J. Watson. (2002). B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107. Oncogene. 21(52). 7923–7932. 19 indexed citations
8.
Rayman, Joseph B., Yasuhiko Takahashi, Vahan B. Indjeian, et al.. (2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes & Development. 16(8). 933–947. 240 indexed citations
9.
Bessa, Maria João, Mark K. Saville, & Roger J. Watson. (2001). Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator. Oncogene. 20(26). 3376–3386. 36 indexed citations
10.
Voorhoeve, P. Mathijs, Roger J. Watson, Peter G. Farlie, René Bernards, & Eric W.‐F. Lam. (1999). Rapid dephosphorylation of p107 following UV irradiation. Oncogene. 18(3). 679–688. 40 indexed citations
11.
Saville, Mark K. & Roger J. Watson. (1998). The cell-cycle regulated transcription factor B-Myb is phosphorylated by Cyclin A/Cdk2 at sites that enhance its transactivation properties. Oncogene. 17(21). 2679–2689. 71 indexed citations
12.
13.
Sala, Arturo, Ida Casella, Teresa Bellón, et al.. (1996). B-myb Promotes S Phase and Is a Downstream Target of the Negative Regulator p107 in Human Cells. Journal of Biological Chemistry. 271(16). 9363–9367. 45 indexed citations
14.
Lyon, Jonathan J. & Roger J. Watson. (1995). Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins. Differentiation. 59(3). 171–178. 11 indexed citations
15.
Lam, Eric W.‐F., et al.. (1995). Cell-cycle regulation of human B-myb transcription. Gene. 160(2). 277–281. 64 indexed citations
16.
Dyson, Paul, Françoise Poirier, & Roger J. Watson. (1989). Expression of c-myb in embryonal carcinoma cells and embryonal stem cells. Differentiation. 42(1). 24–27. 16 indexed citations
17.
18.
Watson, Roger J., John H. Weis, John S. Salstrom, & Lynn W. Enquist. (1984). Bacterial Synthesis of Herpes Simplex Virus Types 1 and 2 Glycoprotein D Antigens.. Journal of Investigative Dermatology. 83(s1). 102s–111s. 6 indexed citations
19.
Watson, Roger J.. (1983). DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene. Gene. 26(2-3). 307–312. 82 indexed citations
20.
Watson, Roger J., John H. Weis, John S. Salstrom, & Lynn W. Enquist. (1982). Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression in Escherichia coli. Science. 218(4570). 381–384. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R J Watson Breakdown of academic impact, for papers by Hans-Gerhard Burgert Breakdown of academic impact, for papers by M A Baluda Breakdown of academic impact, for papers by Laura Menotti Breakdown of academic impact, for papers by M P Calos Breakdown of academic impact, for papers by Philippe Mangeot Breakdown of academic impact, for papers by Rebecca I. Montgomery Breakdown of academic impact, for papers by Jaquelin P. Dudley Breakdown of academic impact, for papers by F Puvion-Dutilleul Breakdown of academic impact, for papers by S D Showalter
Rankless by CCL
2026